On Friday, Dexcom Inc (NASDAQ: DXCM) was 2.59% up from the session before settling in for the closing price of $86.74. A 52-week range for DXCM has been $57.52 – $112.55.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 39.06%. When this article was written, the company’s average yearly earnings per share was at 23.65%. With a float of $386.97 million, this company’s outstanding shares have now reached $392.10 million.
Considering the fact that the conglomerate employs 10300 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 59.39%, operating margin of 15.25%, and the pretax margin is 17.62%.
Dexcom Inc (DXCM) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Dexcom Inc stocks. The insider ownership of Dexcom Inc is 1.31%, while institutional ownership is 93.80%. The most recent insider transaction that took place on Jul 15 ’25, was worth 234,217. In this transaction Director of this company sold 2,750 shares at a rate of $85.17, taking the stock ownership to the 53,871 shares. Before that another transaction happened on Jul 15 ’25, when Company’s EVP, Chief Legal Officer sold 500 for $86.03, making the entire transaction worth $43,015. This insider now owns 94,602 shares in total.
Dexcom Inc (DXCM) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 23.65% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 24.04% during the next five years compared to 39.06% growth over the previous five years of trading.
Dexcom Inc (NASDAQ: DXCM) Trading Performance Indicators
You can see what Dexcom Inc (DXCM) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.32. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.41. Likewise, its price to free cash flow for the trailing twelve months is 60.66.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.33, a number that is poised to hit 0.45 in the next quarter and is forecasted to reach 2.55 in one year’s time.
Technical Analysis of Dexcom Inc (DXCM)
Compared to the last year’s volume of 3.85 million, its volume of 2.26 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 93.34%.
During the past 100 days, Dexcom Inc’s (DXCM) raw stochastic average was set at 99.75%, which indicates a significant increase from 98.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.80 in the past 14 days, which was lower than the 2.51 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $84.77, while its 200-day Moving Average is $78.76. Nevertheless, the first resistance level for the watch stands at $89.81 in the near term. At $90.63, the stock is likely to face the second major resistance level. The third major resistance level sits at $92.19. If the price goes on to break the first support level at $87.43, it is likely to go to the next support level at $85.87. Now, if the price goes above the second support level, the third support stands at $85.05.
Dexcom Inc (NASDAQ: DXCM) Key Stats
There are 392,107K outstanding shares of the company, which has a market capitalization of 34.89 billion. As of now, sales total 4,033 M while income totals 576,200 K. Its latest quarter income was 1,036 M while its last quarter net income were 105,400 K.
